Ocular Therapeutix
OCUL
OCUL
148 hedge funds and large institutions have $685M invested in Ocular Therapeutix in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 58 increasing their positions, 35 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 153 → 148 (-5)
12% less capital invested
Capital invested by funds: $774M → $685M (-$89.5M)
18% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 28
Holders
148
Holding in Top 10
4
Calls
$24.5M
Puts
$11.1M
Top Buyers
| 1 | +$25.2M | |
| 2 | +$14.4M | |
| 3 | +$7.96M | |
| 4 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$7.67M |
| 5 |
Renaissance Technologies
New York
|
+$3.93M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$12.6M | |
| 3 | -$7.97M | |
| 4 |
Wells Fargo
San Francisco,
California
|
-$6.56M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$5.14M |